Chlordiazepoxide Hydrochloride And Clidinium Bromide Capsule
Product Images NDC 72162-1237

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Chlordiazepoxide Hydrochloride And Clidinium Bromide (NDC 72162-1237). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl721621237)

Label for Chlordiazepoxide Hydrochloride and Clidinium Bromide capsules, USP, 5 mg/2.5 mg strength. The label shows the product is in capsule form, contains 100 capsules, and is intended for oral use. It is relabeled by Bryant Ranch Prepack and manufactured by Sunrise Pharmaceutical. The label includes storage instructions and a QR code.*

FDA Label Image

Image Description (Structure Chlordiazepoxide)

Chemical structure diagram of Chlordiazepoxide Hydrochloride, illustrating the molecular arrangement including chlorine, nitrogen, and other functional groups, accompanied by a hydrochloride component.*

FDA Label Image

Image Description (Structure Clidinium)

Chemical structure diagram of the active ingredient Chlordiazepoxide Hydrochloride and Clidinium Bromide, showing molecular bonds and key atoms including oxygen, nitrogen, bromine, and benzene rings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.